Multiplicity and the marginal benefits of bevacizumab in malignant solid tumours

N. D. Gay, D. Tao, V. Prasad

Abstract


-

Full Text:

PDF HTML


DOI: http://dx.doi.org/10.3747/co.26.4845






Copyright © 2019 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)